COVID-19
Critical COVID-19 information and resources. Read More
Skip to Main Content

Research Labs and Programs

University of Miami Leonard M. Miller School of Medicine

Research Programs

F
  • Florida-Puerto Rico Collaboration to Reduce Stroke Disparities

    The Florida Puerto Collaboration to Reduce Stroke Disparities (FL-PR CReSD) aims to address stroke disparities among African Americans and Hispanics and to identify the best approaches to eliminate stroke care disparities in these groups.

Research Labs

A
  • Abreu Lab

    The research focus of Dr. Abreu’s laboratory is inflammatory bowel diseases (IBD) and colon cancer. Dr. Abreu has a special interest in the intimate relationship between the intestinal mucosa of the human host and its associated intestinal microbiota.

B
  • Beurel Lab

    Our research uses a three-pronged approach to understand how the immune system modulates stress responses and susceptibility to depression.

D
  • Davis Lab

    The Davis laboratory has extensive experience and expertise in the evaluation of wound healing agents using various in vitro and in vivo preclinical models.

  • Deo Lab

    We are a bionanotechnology research lab in the Biochemistry & Molecular Biology Department of the University of Miami Miller School of Medicine located in Miami, Florida. We develop novel biotechnology tools employing luminescent proteins and inorganic probes.

  • Dhar Lab

    Dr. Dhar’s team develop macromolecular technologies, which are engineered to nanoparticles and targeted to the mitochondria of cells and they have chemistry-based programs on combination therapy for various cancers.

  • Domínguez-Bendala Lab

    The main lines of research in the Domínguez-Bendala Lab revolve around the development of regenerative strategies for type 1 diabetes, including stem cell differentiation into insulin-producing β-cells and islet regeneration.

G
  • Goldberg Lab

    The Goldberg Lab uses tools from epidemiology, biostatistics, health services research, and empirical bioethics to study and improve outcomes among patients with chronic liver disease and cirrhosis, patients pre- and post-liver transplantation, and the broader population of patients waitlisted for a solid organ transplant.

L
  • Lassance-Soares Lab

    Dr. Lassance-Soares’ Lab studies cellular and molecular mechanism underlying neovascularization and endothelial dysfunction, with a strong focus in translational research. Specifically, Dr. Lassance-Soares interest is to enhance angiogenesis and arteriogenesis in pre-clinical model of hindlimb ischemia.

  • Lembix Lab

    We use different kinds of strategies to look for molecular targets to promote nerve regeneration. Kinases regulate most aspects of cell function. As they are very important in cancer, there are many drugs and compounds as well as cDNA and RNAi libraries that can be used to perturb the Kinome. Neuroscientists should exploit these resources.

M
  • Munson Lab

    The molecular and cellular biology of the bactericidal pore-forming protein Perforin-2 (MPEG1) is a major area of emphasis within the Munson laboratory. Concurrently we are using multidisciplinary approaches to discover and characterize bacterial effectors that subvert or inhibit the bactericidal activity of Perforin-2 with a particular emphasis on enteric and multidrug resistant pathogens.

P
  • Pastori Lab

    Dr. Pastori’s overall research interests focus on the development of translational molecular strategies for the advancement of type 1 diabetes treatments, including regenerative approaches for pancreatic islets and beta-cells.

  • Paus Lab

    Dr Paus’ laboratory focuses on the biology and pathology of human hair follicles, covering a wide range of topics from hair growth control, pigmentation, neuroendocrinology, neurobiology and immunology of the hair follicle via the pathobiology of alopecia areata, lichen planopilaris, and frontal fibrosing alopecia to novel management strategies for chemotherapy-induced alopecia and hair graying.

S
  • Starke Lab

    The goal of the Starke laboratory is to study cerebrovascular diseases from a clinical, translational, therapeutic, and basic science prospective. Our laboratory is uniquely suited to investigate cerebrovascular disease using a multipronged approach consisting of cell culture, experimental aneurysm models, advanced imaging modalities and clinical studies.

  • Stone Lab
Z
  • Zeier Lab

    Our research focuses on neurological disease and its underlying causes to develop promising new therapies. We create induced pluripotent stem cells (iPSCs) — which allow us to study human neurons — to model neurodevelopmental and neurodegenerative diseases using 2D neuronal cultures and 3D cerebral brain organoids. This enables us to investigate how specific mutations lead to these diseases.